ASH23: CAR-T for autoimmune disease, real-world questions and sickle cell’s social media mentions
Bio Pharma Dive
DECEMBER 9, 2023
Study results disclosed at the American Society of Hematology meeting Saturday suggested potential for cell therapy in lupus and pointed out drug trial limitations.
Let's personalize your content